Table 2.
Demographic and clinical‐pathologic features for women EEC vs. non‐EEC
| Clinicopathologic factor | EEC, n = 632 | Non‐EEC, n = 139 | p value |
|---|---|---|---|
| Age at surgery | |||
| Mean (SD) | 60.56 (10.91) | 66.25 (9.76) | <.0001 |
| Median | 61 | 66 | |
| BMI | |||
| Mean (SD) | 39.1 (10.54) | 33.28 (8.1) | <.0001 |
| Median | 38.01 | 31.99 | |
| Race, n (%) | |||
| White | 600 (94.9) | 125 (89.9) | .005 |
| Black | 18 (2.8) | 12 (8.6) | |
| Other | 14 (2.2) | 2 (1.4) | |
| Stage, n (%) | |||
| I | 545 (86.2) | 68 (48.9) | <.0001 |
| II | 17 (2.7) | 5 (3.6) | |
| III | 57 (9) | 43 (30.9) | |
| IV | 13 (2) | 23 (16.5) | |
| Adjuvant therapy received a , n (%) | |||
| Yes | 117 (18.9) | 110 (80.9) | <.0001 |
| No | 503 (81.1) | 26 (19.1) | |
| ND | 1 | 3 | |
| MMR status, n (%) | |||
| Intact | 477 (76.3) | 111 (81) | NS |
| Deficient | 148 (23.7) | 26 (19) | |
| ND | 7 | 2 |
a
Other malignancy n = 11.
Abbreviations: BMI, body mass index; EEC, endometrioid endometrial cancer; MMR, mismatch repair; ND, no data; NS, not significant.